Real-time enrollment status for this bladder cancer clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 10:53 PM UTC
| NCT Number | NCT02138734 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Bladder Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 596 participants |
| Active Locations | 51 sites in the US |
| Sponsor | ImmunityBio, Inc. |
| Last Updated on CT.gov | March 31, 2026 (2 weeks ago) |
As of April 17, 2026: Clinical trial NCT02138734 is currently active_not_recruiting participants. This clinical trial study for bladder cancer is not currently accepting new participants at 51 locations across the United States. The study is sponsored by ImmunityBio, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT02138734 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT02138734 was last updated 2 weeks ago (March 31, 2026). HelloStudys verifies this status automatically.